While the consultation is open you can make a submission at our TGA consultation hub.
We review the submissions carefully. After that the submissions and our decision will be available on the same page at the TGA consultation hub.
Overview
Interim decisions regarding substances discussed at the expert advisory meetings.
This consultation is for interim decisions made in relation to substances that were discussed at the NOVEMBER 2023 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
The interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.
Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.
The closing date for this consultation is close of business 17 April 2024. All submissions received by the deadline will be considered by the delegate before they make an interim decision.
The interim decisions under consultation are detailed in the Public notice of interim decisions NOVEMBER 2023 which can be accessed below:
Substances for which public comment is sought:
ACMS:
- ASTODRIMER SODIUM
- BILASTINE
- BPC-157
- GLYCOPYRRONIUM
- METHENAMINE
- NARATRIPTAN
- PARACETAMOL
ACCS:
- ANIMAL BLOOD PRODUCTS
- BILE ACIDS
JOINT ACMS-ACCS:
- ADRENALINE
- BENZOIC ACID
- MELOXICAM
- PALMITOYLETHANOLAMIDE (PEA)
DELEGATE-ONLY DECISION:
- CAPROMORELIN
All current TGA consultations can be found at the TGA consultation hub.